InVivo Therapeutics to price $15 million public offering of its shares

Underwriters Summer Street and Aegis have a 30-day greenshoe

By Devika Patel

Knoxville, Tenn., Feb. 6 - InVivo Therapeutics Holdings Corp. plans to conduct a $15 million public offering of common stock, according to a preliminary prospectus supplement filed Monday with the Securities and Exchange Commission.

Aegis Capital Corp. and Summer Street Research Partners, the underwriters, have a 30-day greenshoe.

Proceeds will be used for general corporate purposes.

Based in Cambridge, Mass., the company is focused on technologies for spinal cord injuries.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.